Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/25 17:12 | 7/29/25 | LEXX | Health | Drug | Pharmaceutical Preparations | Bunka Christopher | A1 | D | P.dm | 25 | 0.9179 | 0 | 28 | 3 | 910 | I | |||||||||||||||
7/30/25 12:37 | 7/29/25 | LEXX | Health | Drug | Pharmaceutical Preparations | McKechnie William Edward | A6 | D | P.d | 5 | 0.9063 | 0 | 5 | 19 | 31 | D | |||||||||||||||
7/30/25 11:34 | 7/29/25 | LEXX | Health | Drug | Pharmaceutical Preparations | Docherty John Martin | A6 | DO | P,CSO | P.d | 5 | 0.9280 | 0 | 5 | 10 | 59 | D | ||||||||||||||
7/30/25 11:23 | 7/29/25 | LEXX | Health | Drug | Pharmaceutical Preparations | Carle Vanessa | A1 | O | Secretar | P.d | 1 | 0.9100 | 0 | 1 | New | 1 | D | ||||||||||||||
7/30/25 11:14 | 7/29/25 | LEXX | Health | Drug | Pharmaceutical Preparations | Christopher Richard | A1 | DO | CEO | P.d | 14 | 0.9094 | 0 | 15 | 15 | 115 | D | ||||||||||||||
12/3/24 14:03 | 12/2/24 | LEXX | Health | Drug | Pharmaceutical Preparations | Christopher Richard | NY | O | CEO | P.dm | 118 | 2.37 | 0 | 50 | New | 50 | D | ||||||||||||||
8/13/24 10:55 | 8/12/24 | LEXX | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | D | P.d | 5 | 3.13 | 0 | 2 | 53 | 5 | D | |||||||||||||||
2/27/23 10:52 | 2/9/23 | LEXX | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | D | P.d | 4 | 2.84 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |